TIGRIS PHARMACEUTICALS

tigris-pharmaceuticals-logo

Tigris Pharmaceuticals, Inc., a biopharmaceutical company, develops therapeutic technologies for oncology and other areas of unmet medical need. Its products include Aminoflavone that is for the treatment of renal cell, breast, and lung cancer; GGTI-2418, a synthetic peptidomimetic inhibitor of geranylgeranyltransferase, which is for the treatment of lung, breast, pancreatic, and ovarian cancer; GFB-204, a calixarene derivative that is a potent and selective inhibitor of VEGFR and PDGFR tyrosine phosphorylation, which is for the treatment of prostate, pancreas, lung, breast, and renal cell. The company was founded in 2005 and is based in Bonita Springs, Florida.

#SimilarOrganizations #People #Financial #Website #More

TIGRIS PHARMACEUTICALS

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2005-01-01

Address:
Bonita Springs, Florida, United States

Country:
United States

Website Url:
http://www.tigrispharma.com

Total Employee:
1+

Status:
Active

Contact:
239.444.5400

Email Addresses:
[email protected]

Total Funding:
32.49 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta LetsEncrypt SSL By Default Apache AJAX Libraries API SAKURA Internet


Similar Organizations

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

ception-therapeutics-logo

Ception Therapeutics

Ception Therapeutics is a biopharmaceutical company developing novel products to address areas of unmet medical needs.

not_available_image

Keel Pharmaceuticals

Keel Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat type 1 diabetes and other autoimmune diseases.

Current Employees Featured

not_available_image

Edmundo Muniz
Edmundo Muniz President & CEO @ Tigris Pharmaceuticals
President & CEO

not_available_image

Anne White
Anne White COO @ Tigris Pharmaceuticals
COO

Founder


mark-pruzanski_image

Mark Pruzanski

Investors List

sonostar-capital-partners_image

Sonostar Capital Partners

Sonostar Capital Partners investment in Series C - Tigris Pharmaceuticals

riverbank-capital-securities_image

Riverbank Capital Securities

Riverbank Capital Securities investment in Series C - Tigris Pharmaceuticals

wexford-capital_image

Wexford Capital

Wexford Capital investment in Series B - Tigris Pharmaceuticals

ngn-capital_image

NGN Capital

NGN Capital investment in Series B - Tigris Pharmaceuticals

riverbank-capital-securities_image

Riverbank Capital Securities

Riverbank Capital Securities investment in Series B - Tigris Pharmaceuticals

Official Site Inspections

http://www.tigrispharma.com

  • Host name: a904c694c05102f30.awsglobalaccelerator.com
  • IP address: 13.248.169.48
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Tigris Pharmaceuticals"

Tigris Pharmaceuticals - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number 239.444.5400 Tigris Pharmaceuticals, Inc., a biopharmaceutical company, develops therapeutic technologies for oncology and other โ€ฆSee details»

Tigris Pharmaceuticals - The Org

Tigrispharma.com. Headquarters. Bonita Springs, United States. Industries. Biotechnology, +2. Employees. 1-10. Photos. Add photos to showcase Tigris Pharmaceuticalsโ€™s culture. Values. โ€ฆSee details»

www.tigrispharma.com

Www.tigrispharma.comSee details»

Tigris Pharmaceuticals - Company Profile & Staff Directory

Tigris Pharmaceuticals, Inc., a biopharmaceutical company, develops therapeutic technologies for oncology and other areas of unmet medical need. Its products include Aminoflavone that is for โ€ฆSee details»

Tigris Pharmaceuticals - 2025 Company Profile - Tracxn

Feb 25, 2025 Tigris Pharmaceuticals (also known as Kirax Corporation) is a biopharmaceutical company that develops therapeutic technologies for oncology. The company's lead molecule, โ€ฆSee details»

Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive โ€ฆ

Sep 28, 2010 About Tigris Pharmaceuticals, Inc. Tigris Pharmaceuticals, Inc. is a privately held biopharmaceutical company that develops therapeutic technologies to treat oncology and โ€ฆSee details»

Tigris Pharmaceuticals - Contacts, Employees, Board Members, โ€ฆ

Tigris Pharmaceuticals is a biopharmaceutical company developing therapeutic technologies for cancer and other unmet medical needs.See details»

TIGRIS PHARMACEUTICALS INC Bonita Springs FL, 34134 - Cortera

Free Business profile for TIGRIS PHARMACEUTICALS INC at 3359 Woods Edge Cir, Bonita Springs, FL, 34134-3327, US. TIGRIS PHARMACEUTICALS INC specializes in: Commercial โ€ฆSee details»

Tigris Pharmaceuticals - VentureRadar

Tigris Pharmaceuticals VentureRadar profile. Find out more about Tigris Pharmaceuticals including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»

Tigris Pharmaceuticals - Golden

A biopharmaceutical company focuseed on the development of therapeutic technologies for cancer and other medical needsSee details»

Tigris - Products, Competitors, Financials, Employees, โ€ฆ

Headquarters Location. 3359 Woods Edge Circle Suite 103. Bonita Springs, Florida, 34134, United States (239)444-5400See details»

Tigris Pharmaceuticals - Drug pipelines, Patents, Clinical trials

Tigris Trial Enrollment at 135 PatientsStrengthened Balance Sheet with Expected Funds to Complete Tigris Trial Enrollment TORONTO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Spectral โ€ฆSee details»

Tigris Headquarters and Office Locations - Craft.co

Tigris is headquartered in Toronto, 100 King St W, Canada, and has 2 office locations.See details»

Tigris Pharmaceuticals Completes $6.5 Million Private Placement

Sep 29, 2010 BONITA SPRINGS, Fla. and NEW YORK, Sept. 28 /PRNewswire/ --Tigris Pharmaceuticals, Inc., a privately held drug development company, announced today that it โ€ฆSee details»

Tigris Pharmaceuticals - Funding, Financials, Valuation & Investors

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Sep 28, 2010: Series C - Tigris โ€ฆSee details»

Tigris Pharmaceuticals-ๅŠจ่„‰็ฝ‘ - vbdata.cn

Tigris Pharmaceuticals, Inc. ๆ˜ฏไธ€ๅฎถ็”Ÿ็‰ฉๅˆถ่ฏๅ…ฌๅธ๏ผŒไธบ่‚ฟ็˜คๅญฆๅ’Œๅ…ถไป–ๆœชๆปก่ถณๅŒป็–—้œ€ๆฑ‚็š„้ข†ๅŸŸๅผ€ๅ‘ๆฒป็–—ๆŠ€ๆœฏใ€‚ๅ…ถไบงๅ“ๅŒ…ๆ‹ฌ็”จไบŽๆฒป็–—่‚พ็ป†่ƒž็™Œใ€ไนณ่…บ็™Œๅ’Œ่‚บ็™Œ็š„ๆฐจๅŸบ้ป„้…ฎ๏ผ›GGTI-2418๏ผŒไธ€็งๅˆๆˆ็š„ โ€ฆSee details»

Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement

Sep 28, 2010 BONITA SPRINGS, Fla. and NEW YORK, Sept. 28 /PRNewswire/ --Tigris Pharmaceuticals, Inc., a privately held drug development company, announced today that it โ€ฆSee details»

Tigris Pharmaceuticals Completes $16 Million Private ... - BioSpace

Jan 16, 2007 More information on Tigris can be found at www.tigrispharma.com. About NGN Capital LLC. NGN Capital is a global healthcare venture capital investment firm which is โ€ฆSee details»

Tigris Pharmaceuticals Culture | Comparably

Learn about Tigris Pharmaceuticals' culture, see what work's like, read reviews, and find job opportunities.See details»

Tigris Lifesciences โ€“ A Brand to Reckon Globally

TIGRIS is a spirited organization handled by the experienced Mr. Tejpal Singh.With a experience of over 35 years in the pharmaceutical industry, he seeks to fill in the crucial industry โ€ฆSee details»

linkstock.net © 2022. All rights reserved